Fraser E Ashton

Title: Fraser E Ashton: Innovator in Bacterial Identification

Introduction

Fraser E Ashton is a notable inventor based in Lucerne, California. He has made significant contributions to the field of microbiology, particularly in the identification of bacterial strains. His work has implications for public health and medical diagnostics.

Latest Patents

Fraser E Ashton holds a patent for the "Identification of Neisseria gonorrhoeae." This invention involves a reagent and test designed for the identification of the bacterium Neisseria gonorrhoeae. The patent utilizes a lipopolysaccharide antigen, which is common to various strains of N. gonorrhoeae. The process involves inoculating fowl with this antigen and using the serum from the fowl, which contains antibodies that cause agglutination of all N. gonorrhoeae strains. The identification test consists of adding the recovered antibody reagent to a suspension of bacterial cells, where the occurrence of cell agglutination indicates a positive test for N. gonorrhoeae. Fraser E Ashton has 1 patent to his name.

Career Highlights

Fraser E Ashton is associated with Canadian Patents & Development Ltd., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in the identification of bacterial infections, which is crucial for effective treatment and management.

Collaborations

Fraser has collaborated with notable colleagues, including Rebecca Wallace and Malcolm B Perry. Their combined expertise has likely enhanced the development and application of his inventions.

Conclusion

Fraser E Ashton is a distinguished inventor whose work in bacterial identification has made a significant impact in the field of microbiology. His innovative approach to identifying Neisseria gonorrhoeae demonstrates the importance of research and development in public health.